-
Locations
Hospitals and Multispecialty Locations
-
Patients & Visitors
Tuesday, August 3, 2021
Warwick, RI (Aug. 3, 2021) – Yale New Haven Health has opened a new Northeast Medical Group urology office at 176 Toll Gate Road, Suite 301, Warwick, RI.
The office is currently welcoming new patients. To schedule an appointment please call 401-244-9090.
The office is staffed by providers from Northeast Medical Group (NEMG) who are affiliated with Westerly Hospital, a member of Yale New Haven Health. The team includes Joseph Renzulli, MD, regional medical director and chief of urology at Westerly Hospital; Joseph Heineman, MD; E. Bradley Miller, MD; Emily Henault, PA; and Lauren Houle, APRN.
In Warwick, NEMG urologists offer comprehensive and coordinated care to both men and women, as well as children. Conditions specific to men include erectile dysfunction, male infertility, enlarged prostate and testicular cancer. Female urology involves the diagnosis and treatment of urinary tract disorders most prevalent in women. Advanced, minimally invasive procedures are conveniently performed at Westerly Hospital.
9/13/2024
Yale New Haven Health earns national recognition for promoting safe sleep practicesNEW HAVEN, CT (September 11, 2024) – Yale New Haven Health System (YNHHS) recently announced that the National Safe Sleep Hospital Certification Program recognized the health system for educating parents about safe sleep practices for newborns.
9/6/2024
Bridgeport Hospital awarded reaccreditation from Commission on CancerBridgeport, CT (September 6, 2024) – The Commission on Cancer (CoC), a quality program of the American College of Surgeons (ACoS), has granted a new three-year accreditation to Bridgeport Hospital. The hospital was recognized as an Academic Comprehensive Cancer Program.
9/5/2024
Smilow announces first administration of unprecedented radiotherapy treatmentNew Haven, CT (Sept. 5, 2024) – Smilow Cancer Hospital at Yale New Haven today announced they successfully delivered the world’s first radiotherapy treatment plan that efficiently combines different radiotherapy modalities to treat a patient with metastatic cancer.
